Records containing: Paraganglioma, Malignant
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-06-12A Phase 2 Study of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma
-
CLINICAL_TRIALS study record update · 2023-08-29Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound in Patients With Pheochromocytoma or Paraganglioma
-
CLINICAL_TRIALS study record update · 2023-06-02A Study on the Efficacy and Safety of Penpulimab in the Treatment of Metastatic Pheochromocytoma/Paraganglioma Patients Who Fail to Other Systemic Treatment
-
CLINICAL_TRIALS study record update · 2023-05-15The Efficacy and Safety of Temozolomide in Patients With Metastatic Pheochromocytoma or Paraganglioma